Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed CFO Quarterly results CFO resigned CC transcript Appointed director
|
OSIRIS THERAPEUTICS, INC. (OSIR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/17/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
03/12/2019 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
03/12/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
11/26/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
11/08/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
09/17/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
09/11/2018 |
8-K
| Resignation/termination of a director |
07/10/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
07/02/2018 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
06/28/2018 |
8-K
| Submission of Matters to a Vote of Security Holders |
06/04/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
05/10/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
04/19/2018 |
8-K
| Other Events |
02/08/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/06/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/14/2017 |
8-K
| Resignation/termination of a director |
12/05/2017 |
8-K
| Other Events |
06/26/2017 |
8-K
| Quarterly results |
05/31/2017 |
8-K
| Form 8-K - Current report |
05/19/2017 |
8-K
| Form 8-K - Current report |
05/17/2017 |
8-K
| Form 8-K - Current report |
03/27/2017 |
8-K
| Form 8-K - Current report |
03/10/2017 |
8-K
| Form 8-K - Current report |
02/10/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/31/2017 |
8-K
| Form 8-K - Current report |
01/12/2017 |
8-K
| Form 8-K - Current report |
12/02/2016 |
8-K
| Form 8-K - Current report |
11/21/2016 |
8-K
| Form 8-K - Current report |
10/14/2016 |
8-K
| Other Events |
10/07/2016 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
10/06/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
09/16/2016 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
08/17/2016 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs:
|
"Osiris Provides Update Regarding NASDAQ Listing Matters COLUMBIA, Md. — August 17, 2016 - Osiris Therapeutics, Inc. today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market . As previously disclosed, on each of March 17, 2016 and May 12, 2016 the Company received a notification from NASDAQ indicating that, as a result of the Company not timely filing with the Securities and Exchange Commission its Annual Report on Form 10-K for the year ended December 31, 2015 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2016 , respectively, the Company failed to comply with the periodic filing requirements in NASDAQ Listing Rule 5250 . On August 12, 2016, the Company received an anticipated letter from NASDAQ noting that th..." |
|
06/14/2016 |
8-K
| Form 8-K - Current report |
|
|
|